All
Allergan, Pfizer merger to boost R&D, cosmetic options
January 11th 2016Following the merger of Pfizer and Allergan, Brent Saunders, Allergan's chief executive officer, will be president and chief operating officer of the newly combined company, called Pfizer plc. He spoke to us about the long-term impact the merger will have on the company and on the dermatology industry.
Antimicrobial stewardship programs aim to curb resistance problem
January 11th 2016Acute bacterial skin and skin structure infections are associated with unnecessary use of broad-spectrum antibiotics, leading to antibiotic resistance. Antimicrobial stewardship programs could be a very effective and useful approach to help stop the alarming trend of antibiotic resistance. Several strategies help optimize outcomes.
How to educate men on aesthetic treatment
January 11th 2016Men are flocking to dermatologists for aesthetic procedures, and they usually know what they want aesthetic procedures to accomplish, but they may not know how to express what they want or what options are available, says an expert at the American Society for Dermatologic Surgery annual meeting in Chicago. Learn more
Choosing the right fat reduction technique
January 8th 2016The FDA’s recent clearance of SculpSure (Cynosure) shines a light on the billowing demand for noninvasive lipolysis and the promise that unwanted fat will vanish without a prick or incision. Dermatologists and others faced with the daunting decision of which technologies to purchase or rent should also know there are clear differences between what invasive and noninvasive fat reduction can accomplish.
Can you maintain response after biologic holiday?
January 8th 2016Melinda Gooderham, M.D., MSc, FRCPCPatients might stop taking their biologic medications for a variety of reasons. When patients do stop their biologic therapy, clinicians need to consider that some biologic therapies are better at recapturing response than others. learn more
What physicians need to consider when selling a practice
January 8th 2016When considering selling a practice, physicians must consider the near- and long-term objectives of the practice's owners and of the acquiring organization, as well as how much autonomy the proposed arrangement allows the acquired practice, experts say.
How personality type impacts dermatology practice
January 8th 2016Based on the Myers-Briggs Type Indicator (MBTI), one expert explains how each of eight mental processes may impact interactions with patients and staff. By understanding our default processes, we can begin to identify blind-spots in our ways of interacting with others
Why social media is important in dermatology
January 8th 2016Dermatology Times presents a year-long exploration of social media-the many ways that it impacts the field of dermatology as well as your medical practice. The series will provide strategies and tips for how you can use social to best effect: how to get started, which platforms to use, secrets for incorporating video, AMA guidelines, and more.
Moving toward personalized medicine for melanoma
January 7th 2016New research indicates that cutaneous melanoma is the most mutation-driven form of all cancers. While research has determined that there is more than one form of cutaneous melanoma, forms with more mutations may respond better to immunotherapies that have been approved by the Federal Drug Administration (FDA) since 2011. Learn more
Risk Factors for Melanoma and Genetic Testing
January 7th 2016While one German study has shown that population-wide screening for melanoma could dramatically reduce mortality, potential problems with the strategy include cost due to the overall rarity of the disease, patient compliance, and difficulties identifying patients likely to develop melanoma. Therefore, scientists are developing prediction models to identify those at high risk for melanoma, which can include genetic factors. Learn more
How to use big data to treat and manage diseases
January 7th 2016Precision medicine appears to be the future of healthcare and the use of big data is proving to be invaluable in achieving this goal. The vast amounts of molecular and other valuable data currently being collected at huge databases and used to create personalized medicine is part of a grand and inevitable formula to revolutionize modern medicine.
High-risk skin cancer needs multidisciplinary management
January 7th 2016Immunosuppressed patients have a greater risk for developing high-risk non-melanoma skin cancer, which can typically be more aggressive in this patient population. As such, a multidisciplinary approach is required when contemplating appropriate treatment and management of this patient population.
Did I violate the Stark Statute?
January 7th 2016The essence of the Stark statute is a prohibition on a physician (or immediate family member) referring a Medicare patient to an entity with which the physician or family member has a financial relationship, when the referral is for any of a targeted list of “designated health services” (DHS), unless the financial relationship meets one of a host of exceptions. For dermatology, the primary impact of this law is on relationships between dermatology practices and dermatopathologists. Because clinical laboratory services are on the DHS list, the complexities are considerable.